Ravi S. Chari, SVP-Clinical Excellence at HCA Holdings, Inc. (HCA), sold 11,166 shares at $90.78 ($1.0M) on 2015-08-06, disclosed to the SEC on 2015-08-07.
Scheduled sale ($1.0M) by SVP-Clinical Excellence under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| HCA | SELL | 2017-02-03 | $1.3M | — | Filing → |